MedPath

黑龙江龙德药业有限公司

Ownership
-
Established
2013-04-01
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

7

NMPA:7

Drug Approvals

Cefalexin Tablets

Product Name
头孢氨苄片
Approval Number
国药准字H23021842
Approval Date
Jan 15, 2024
NMPA

Procaterol Hydrochloride Granules

Product Name
盐酸丙卡特罗颗粒
Approval Number
国药准字H20041825
Approval Date
Jul 15, 2023
NMPA

Paracetamol,Caffein,Atificial Cow-bezoar and chlorphenamine Maleate capsules

Product Name
氨咖黄敏胶囊
Approval Number
国药准字H23022963
Approval Date
Dec 28, 2020
NMPA

Clarithromycin Capsules

Product Name
绿舒
Approval Number
国药准字H19990041
Approval Date
Dec 28, 2020
NMPA

Norfloxacin Capsules

Product Name
诺氟沙星胶囊
Approval Number
国药准字H23021841
Approval Date
Dec 28, 2020
NMPA

Aspirin Enteric-coated Tablets

Product Name
阿司匹林肠溶片
Approval Number
国药准字H23021839
Approval Date
Dec 28, 2020
NMPA

Metronidazole Tablets

Product Name
甲硝唑片
Approval Number
国药准字H23021840
Approval Date
Dec 28, 2020
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.